Neurocrine Biosciences Reports Mixed Q4
Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while ...
insurancebusinessmag50m
Legal & General to offload US arm
According to Bloomberg, Meiji Yasuda will acquire full ownership of L&G’s US protection business while also securing a 20% ...